COPD can lead to abnormalities in oxygenation as well as ventilation. Thanks to pioneering work by Dr Thomas Petty, supplemental oxygen therapy has been shown to improve morbidity and mortality for individuals with COPD and severe daytime hypoxemia. However, efforts to augment ventilation have been less uniformly successful. Recent studies employing a so-called high-intensity noninvasive ventilation strategy, which used high inspiratory pressures and backup breathing frequency to reduce arterial carbon dioxide levels, have shown improved quality of life and reduced mortality. Thus, efforts are underway to better identify and treat patients with COPD who might benefit from noninvasive ventilation, though many practical questions remain.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018; 392(10159):1736-1788.
PettyTL, FiniganMM. Clinical evaluation of prolonged ambulatory oxygen therapy in chronic airway obstruction. Am J Med, 1968; 45(2):242-252.
6.
PettyTL. Studies of domiciliary oxygen in a common cause. Thorax, 1989; 44(7):588-590.
7.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med, 1980; 93(3):391-398.
8.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet, 1981; 1(8222):681-686.
9.
PettyTL. CO2 can be good for you!. Chest, 2006; 129(2):494.
DouglasNJ, WhiteDP, WeilJV, PickettCK, ZwillichCW. Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis, 1982; 126(5):758-762.
12.
DouglasNJ, WhiteDP, PickettCK, WeilJV, ZwillichCW. Respiration during sleep in normal man. Thorax, 1982; 37(11):840-844.
13.
McNicholasWT, FitzgeraldMX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed), 1984; 289(6449):878.
14.
KrachmanSL, ChatilaW, MartinUJ, NugentT, CrocettiJ, GaughanJ, et al. Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest, 2005; 128(5):3221-3228.
15.
PriceD, SmallM, MilliganG, HigginsV, GilEG, EstruchJ. Impact of night-time symptoms in COPD: a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis, 2013; 8:595-603.
16.
Geiger-BrownJ, LindbergS, KrachmanS, McEvoyCE, CrinerGJ, ConnettJE, et al. Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2015; 10:389-397.
O'DonoghueFJ, CatchesidePG, EckertDJ, McEvoyRD. Changes in respiration in NREM sleep in hypercapnic chronic obstructive pulmonary disease. J Physiol, 2004; 559(Pt 2):663-673.
19.
ChaouatA, WeitzenblumE, KesslerR, CharpentierC, EhrhartM, Levi-ValensiP, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J, 1997; 10(8):1730-1735.
20.
FletcherEC, MillerJ, DivineGW, FletcherJG, MillerT. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mm Hg. Chest, 1987; 92(4):604-608.
21.
LewisCA, FergussonW, EatonT, ZengI, KolbeJ. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax, 2009; 64(2):133-138.
22.
PeppardPE, YoungT, BarnetJH, PaltaM, HagenEW, HlaKM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol, 2013; 177(9):1006-1014.
23.
SandersMH, NewmanAB, HaggertyCL, RedlineS, LebowitzM, SametJ, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med, 2003; 167(1):7-14.
24.
López-AcevedoMN, Torres-PalaciosA, Elena Ocasio-TascónM, Campos-SantiagoZ, Rodríguez-CintrónW. Overlap syndrome: an indication for sleep studies? A pilot study. Sleep Breath, 2009; 13(4):409-413.
25.
SolerX, GaioE, PowellFL, RamsdellJW, LoredoJS, MalhotraA, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc, 2015; 12(8):1219-1225.
26.
MalhotraA, SchwartzAR, SchneiderH, OwensRL, DeYoungP, HanMK, et al. Research priorities in pathophysiology for sleep-disordered breathing in patients with chronic obstructive pulmonary disease. An official American Thoracic Society research statement. Am J Respir Crit Care Med, 2018; 197(3):289-299.
27.
OwensRL, MacreaMM, TeodorescuM. The overlaps of asthma or COPD with OSA: a focused review. Respirology, 2017; 22(6):1073-1083.
28.
OwensRL, MalhotraA. Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care, 2010; 55(10):1333-1344.
29.
MarinJM, SorianoJB, CarrizoSJ, BoldovaA, CelliBR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med, 2010; 182(3):325-331.
30.
StanchinaML, WelickyLM, DonatW, LeeD, CorraoW, MalhotraA. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med, 2013; 9(8):767-772.
31.
JaoudeP, KufelT, El-SolhAA. Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome. Lung, 2014; 192(2):251-258.
32.
KonikkaraJ, TavellaR, WillesL, KavuruM, SharmaS. Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation is associated with reduced readmission. Hosp Pract (1995), 2016; 44(1):41-47.
33.
AlfordNJ, FletcherEC, NickesonD. Acute oxygen in patients with sleep apnea and COPD. Chest, 1986; 89(1):30-38.
34.
GoldsteinRS, RamcharanV, BowesG, McNicholasWT, BradleyD, PhillipsonEA. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med, 1984; 310(7):425-429.
35.
SolerX, LiaoSY, MarinJM, Lorenzi-FilhoG, JenR, DeYoungP, et al. Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): the challenge to predict OSA in advanced COPD. PloS One, 2017; 12(5):e0177289.
36.
RestaO, Foschino BarbaroMP, BrindicciC, NocerinoMC, CaratozzoloG, CarbonaraM. Hypercapnia in overlap syndrome: possible determinant factors. Sleep Breath, 2002; 6(1):11-18.
37.
KesslerR, ChaouatA, WeitzenblumE, OswaldM, EhrhartM, ApprillM, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J, 1996; 9(4):787-794.
38.
ShapiroSH, ErnstP, Gray-DonaldK, MartinJG, Wood-DauphineeS, BeaupréA, et al. Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Lancet, 1992; 340(8833):1425-1429.
39.
DuivermanML. Noninvasive ventilation in stable hypercapnic COPD: what is the evidence?. ERJ Open Res, 2018; 4(2):00012-2018.
40.
McEvoyRD, PierceRJ, HillmanD, EstermanA, EllisEE, CatchesidePG, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax, 2009; 64(7):561-566.
41.
WindischW, HaenelM, StorreJH, DreherM. High-intensity non-invasive positive pressure ventilation for stable hypercapnic COPD. Int J Med Sci, 2009; 6(2):72-76.
KöhnleinT, WindischW, KöhlerD, DrabikA, GeiselerJ, HartlS, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med, 2014; 2(9):698-705.
44.
MurphyPB, RehalS, ArbaneG, BourkeS, CalverleyPMA, CrookAM, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA, 2017; 317(21):2177-2186.
45.
StruikFM, SprootenRT, KerstjensHA, BladderG, ZijnenM, AsinJ, et al. Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study. Thorax, 2014; 69(9):826-834.
46.
ChuCM, ChanVL, LinAW, WongIW, LeungWS, LaiCK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax, 2004; 59(12):1020-1025.
47.
DonaldsonGC, SeemungalTA, BhowmikA, WedzichaJA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 2002; 57(10):847-852.
48.
Soler-CataluñaJJ, Martínez-GarcíaMA, Román SánchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 2005; 60(11):925-931.
49.
ErganB, OczkowskiS, RochwergB, CarlucciA, ChatwinM, CliniE, et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J, 2019; 54(3):1901003.
50.
MacreaM, OczkowskiS, RochwergB, BransonRD, CelliB, ColemanJM3rd, et al. Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med, 2020; 202(4):e74-e87.
51.
GuyattGH, OxmanAD, KunzR, Falck-YtterY, VistGE, LiberatiA, et al. Going from evidence to recommendations. BMJ, 2008; 336(7652):1049-1051.
52.
DuivermanML, MaaghP, MagnetFS, SchmoorC, Arellano-MaricMP, MeissnerA, et al. Impact of high-intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study. Respir Res, 2017; 18(1):76.
53.
DreherM, StorreJH, SchmoorC, WindischW. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax, 2010; 65(4):303-308.
54.
ParreiraVF, JounieauxV, AubertG, DuryM, DelgustePE, RodensteinDO. Nasal two-level positive-pressure ventilation in normal subjects. Effects of the glottis and ventilation. Am J Respir Crit Care Med, 1996; 153(5):1616-1623.
55.
DuivermanML, VonkJM, BladderG, van MelleJP, NieuwenhuisJ, HazenbergA, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial. Thorax, 2020; 75(3):244-252.
56.
Arellano-MaricMP, GregorettiC, DuivermanM, WindischW. Long-term volume-targeted pressure-controlled ventilation: sense or nonsense?. Eur Respir J, 2017; 49(6):1602193.
57.
ColemanJM3rd, WolfeLF, KalhanR. Noninvasive ventilation in chronic obstructive pulmonary disease. Ann Am Thorac Soc, 2019; 16(9):1091-1098.
58.
U.S. Department of Health and Human Services, Office of the Inspector General. Escalating Medicare billing for ventilators raises concerns. Available at: https://oig.hhs.gov/oei/reports/oei-12-15-00370.asp. Accessed April 6, 2021.
MarikPE, DesaiH. Characteristics of patients with the “malignant obesity hypoventilation syndrome” admitted to an ICU. J Intensive Care Med, 2013; 28(2):124-130.
61.
MasaJF, MokhlesiB, BenítezI, Gomez de TerrerosFJ, Sánchez-QuirogaMA, RomeroA, et al. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial. Lancet, 2019; 393(10182):1721-1732.
